El MIT identificó una enzima clave en el origen del cáncer de pulmón

Researchers at the Massachusetts Institute of Technology (MIT) have identified a key enzyme involved in the origin of lung cancer. The scientific team discovered that blocking the enzyme caspase-1 using a drug that has already been tested in humans successfully reduces the risk of lung tumors in laboratory mice.

This finding points toward a potential new prevention strategy specifically targeted at individuals who are at high risk of developing lung cancer.